NYSE:CANO
Cano Health
- Stock
Last Close
2.35
02/02 21:00
Market Cap
12.43M
Beta: −0.04
Volume Today
172.60K
Avg: 7.02M
PE Ratio
−0.01
PFCF: −0.07
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|
average inventory | 1.01M - | 553.50K 45.44% | |||
average payables | 52.07M - | 89.25M 71.41% | |||
average receivables | 100.39M - | 183.62M 82.91% | |||
book value per share | 0.30 - | 1.87 526.22% | 1.16 37.76% | ||
capex per share | -0.06 - | -0.07 29.67% | -0.20 177.46% | -0.23 12.16% | |
capex to depreciation | -1.36 - | -0.65 52.18% | -0.69 6.48% | -0.55 21.36% | |
capex to operating cash flow | 0.60 - | 1.31 117.14% | 0.27 79.55% | 0.34 26.63% | |
capex to revenue | -0.03 - | -0.01 43.65% | -0.02 47.04% | -0.02 15.29% | |
cash per share | 4.36 - | 0.96 78.03% | 0.12 86.97% | ||
days of inventory on hand | 0.51 - | 0.29 43.28% | |||
days payables outstanding | 17.18 - | 18.83 9.60% | 16.65 11.57% | ||
days sales outstanding | 29.56 - | 30.26 2.37% | 31.16 2.96% | ||
debt to assets | 0.76 - | 0.50 34.38% | 0.62 25.15% | ||
debt to equity | 9.37 - | 3.34 64.35% | 4.70 40.76% | ||
dividend yield | 0.00 - | 0.05 3,297.09% | |||
earnings yield | -0.04 - | -0.03 10.76% | -0.08 141.05% | -1.43 1,756.76% | |
enterprise value | 2.66B - | 2.42B 9.00% | 1.47B 39.18% | ||
enterprise value over ebitda | 43.52 - | -45.51 204.57% | 1.52K 3,436.17% | ||
ev to operating cash flow | -288.11 - | -18.84 93.46% | -10.06 46.58% | ||
ev to sales | 3.20 - | 1.50 52.98% | 0.54 64.26% | ||
free cash flow per share | -0.15 - | -0.13 14.00% | -0.96 645.33% | -0.89 6.45% | |
free cash flow yield | -0.03 - | -0.01 67.93% | -0.11 1,021.76% | -0.65 508.43% | |
graham net net | 1.27 - | -6.34 600.72% | -5.62 11.35% | ||
graham number | 1.69 - | 5.37 216.70% | 7.15 33.30% | ||
income quality | 0.78 - | 0.13 83.38% | 1.10 747.22% | 0.34 68.97% | |
intangibles to total assets | 0 - | 0.75 Infinity% | 0.74 0.78% | 0.66 11.24% | |
interest coverage | 1.06 - | 1.25 17.89% | -2.00 259.52% | -1.43 28.27% | |
interest debt per share | 3.00 - | 6.55 118.08% | 5.76 12.05% | ||
inventory turnover | 722.72 - | 1.27K 76.29% | |||
invested capital | 9.37 - | 3.34 64.35% | 4.70 40.76% | ||
market cap | 831.22M - | 2.23B 168.20% | 1.52B 31.85% | 300.26M 80.24% | |
net current asset value | -453.55M - | -1.03B 126.60% | -1.09B 6.44% | ||
net debt to ebitda | 7.06 - | -16.95 340.29% | 1.21K 7,228.77% | ||
net income per share | -0.18 - | -0.43 139.33% | -0.68 60.16% | -1.95 185.49% | |
operating cash flow per share | -0.09 - | -0.06 40.28% | -0.75 1,256.94% | -0.67 11.42% | |
payables turnover | 21.24 - | 19.38 8.76% | 21.92 13.08% | ||
receivables turnover | 12.35 - | 12.06 2.31% | 11.71 2.88% | ||
research and ddevelopement to revenue | |||||
return on tangible assets | -0.46 - | -0.21 54.01% | -0.65 207.26% | ||
revenue per share | 2.17 - | 5.00 130.11% | 9.44 88.69% | 12.50 32.40% | |
roe | -1.43 - | -0.37 74.42% | -1.68 358.67% | ||
roic | 0.08 - | -0.07 180.85% | -0.05 18.80% | ||
sales general and administrative to revenue | 0.16 - | 0.13 23.62% | 0.16 25.31% | ||
shareholders equity per share | 0.30 - | 1.87 526.22% | 1.16 37.76% | ||
stock based compensation to revenue | 0.00 - | 0.00 26.08% | 0.02 2,638.46% | 0.02 21.07% | |
tangible asset value | -411.06M - | -796.72M 93.82% | -779.86M 2.12% | ||
tangible book value per share | -2.47 - | -4.67 88.98% | -3.56 23.85% | ||
working capital | 43.84M - | 156.20M 256.30% | 132.31M 15.29% |
All numbers in USD (except ratios and percentages)